newsfilter
← Latest News
PR Newswire·

enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company

Business combination transaction completed with Forbion European Acquisition Corp. Clinical stage biotechnology company with EG-70 lead program in...